Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Nexiguran ziclumeran by Regeneron Pharmaceuticals for Familial Amyloid Cardiomyopathy: Likelihood of Approval
Nexiguran ziclumeran is under clinical development by Regeneron Pharmaceuticals and currently in Phase III for Familial Amyloid Cardiomyopathy. According to...